Jayakumar A, Huang W Y, Raetz B, Chirala S S, Wakil S J
Verna and Marrs McLean Department of Biochemistry, Baylor College of Medicine, Houston, TX 77030, USA.
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14509-14. doi: 10.1073/pnas.93.25.14509.
We engineered a full-length (8.3-kbp) cDNA coding for fatty acid synthase (FAS; EC 2.3.1.85) from the human brain FAS cDNA clones we characterized previously. In the process of accomplishing this task, we developed a novel PCR procedure, recombinant PCR, which is very useful in joining two overlapping DNA fragments that do not have a common or unique restriction site. The full-length cDNA was cloned in pMAL-c2 for heterologous expression in Escherichia coli as a maltose-binding protein fusion. The recombinant protein was purified by using amylose-resin affinity and hydroxylapatite chromatography. As expected from the coding capacity of the cDNA expressed, the chimeric recombinant protein has a molecular weight of 310,000 and reacts with antibodies against both human FAS and maltose-binding protein. The maltose-binding protein-human FAS (MBP-hFAS) catalyzed palmitate synthesis from acetyl-CoA, malonyl-CoA, and NADPH and exhibited all of the partial activities of FAS at levels comparable with those of the native human enzyme purified from HepG2 cells. Like the native HepG2 FAS, the products of MBP-hFAS are mainly palmitic acid (> 90%) and minimal amounts of stearic and arachidic acids. Similarly, a human FAS cDNA encoding domain I (beta-ketoacyl synthase, acetyl-CoA and malonyl-CoA transacylases, and beta-hydroxyacyl dehydratase) was cloned and expressed in E. coli using pMAL-c2. The expressed fusion protein, MBP-hFAS domain I, was purified to apparent homogeneity (M(r) 190,000) and exhibited the activities of the acetyl/malonyl transacylases and the beta-hydroxyacyl dehydratase. In addition, a human FAS cDNA encoding domains II and III (enoyl and beta-ketoacyl reductases, acyl carrier protein, and thioesterase) was cloned in pET-32b(+) and expressed in E. coli as a fusion protein with thioredoxin and six in-frame histidine residues. The recombinant fusion protein, thioredoxin-human FAS domains II and III, that was purified from E. coli had a molecular weight of 159,000 and exhibited the activities of the enoyl and beta-ketoacyl reductases and the thioesterase. Both the MBP and the thioredoxin-His-tags do not appear to interfere with the catalytic activity of human FAS or its partial activities.
我们从先前鉴定的人脑海脂肪酸合酶(FAS;EC 2.3.1.85)cDNA克隆中构建了一个编码脂肪酸合酶的全长(8.3-kbp)cDNA。在完成这项任务的过程中,我们开发了一种新型PCR程序——重组PCR,它在连接两个没有共同或独特限制酶切位点的重叠DNA片段时非常有用。全长cDNA被克隆到pMAL-c2中,以便在大肠杆菌中作为麦芽糖结合蛋白融合体进行异源表达。重组蛋白通过使用直链淀粉树脂亲和层析和羟基磷灰石层析进行纯化。正如所表达的cDNA编码能力所预期的那样,嵌合重组蛋白的分子量为310,000,并且能与抗人FAS和麦芽糖结合蛋白的抗体发生反应。麦芽糖结合蛋白-人FAS(MBP-hFAS)催化从乙酰辅酶A、丙二酰辅酶A和NADPH合成棕榈酸,并表现出FAS的所有部分活性,其水平与从HepG2细胞中纯化的天然人酶相当。与天然HepG2 FAS一样,MBP-hFAS的产物主要是棕榈酸(>90%)以及少量的硬脂酸和花生酸。同样,一个编码结构域I(β-酮脂酰合酶、乙酰辅酶A和丙二酰辅酶A转酰基酶以及β-羟基脂酰脱水酶)的人FAS cDNA被克隆,并使用pMAL-c2在大肠杆菌中表达。所表达的融合蛋白MBP-hFAS结构域I被纯化至表观均一(M(r) 190,000),并表现出乙酰/丙二酰转酰基酶和β-羟基脂酰脱水酶的活性。此外,一个编码结构域II和III(烯酰和β-酮脂酰还原酶、酰基载体蛋白和硫酯酶)的人FAS cDNA被克隆到pET-32b(+)中,并在大肠杆菌中作为与硫氧还蛋白和六个框内组氨酸残基的融合蛋白进行表达。从大肠杆菌中纯化的重组融合蛋白硫氧还蛋白-人FAS结构域II和III的分子量为159,000,并表现出烯酰和β-酮脂酰还原酶以及硫酯酶的活性。MBP和硫氧还蛋白-组氨酸标签似乎都不会干扰人FAS的催化活性或其部分活性。